Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biosimilars Forum: How Do You Create A Brand-Generic Coalition? Don’t Talk About Naming

Executive Summary

Group of 11 companies is focusing on biosimilar reimbursement and educational issues important to market formation.

You may also be interested in...

PhRMA Embraces Teva Across Brand-Generic Divide

PhRMA accepts Teva's request for membership; BIO rejected Teva five years ago.

Biosimilar User Fee Talks Begin With Industry Negotiating Amongst Itself

FDA asks negotiators from the four industry groups to coordinate proposed changes as BsUFA renewal talks get underway.

For Generics Industry, Will Larger Firms Mean Weaker Lobbying?

New CEO Chip Davis wants GPhA sitting at the table in policy debates rather than being on the menu, but industry consolidation means there are fewer dues-paying members to fill the chairs.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts